UBS Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $134K | Sell |
29,699
-84,881
| -74% | -$339K | ﹤0.01% | 6848 |
|
|
2025
Q4 | $437K | Sell |
114,580
-143,419
| -56% | -$558K | ﹤0.01% | 6168 |
|
|
2025
Q3 | $833K | Buy |
257,999
+149,662
| +138% | +$561K | ﹤0.01% | 5717 |
|
|
2025
Q2 | $313K | Buy |
108,337
+63,427
| +141% | +$147K | ﹤0.01% | 6406 |
|
|
2025
Q1 | $96.6K | Sell |
44,910
-8,221
| -15% | -$26K | ﹤0.01% | 7073 |
|
|
2024
Q4 | $206K | Buy |
53,131
+33,257
| +167% | +$220K | ﹤0.01% | 6436 |
|
|
2024
Q3 | $130K | Buy |
19,874
+2,202
| +12% | +$17.7K | ﹤0.01% | 6168 |
|
|
2024
Q2 | $128K | Sell |
17,672
-8,926
| -34% | -$68.4K | ﹤0.01% | 5989 |
|
|
2024
Q1 | $202K | Sell |
26,598
-1,441
| -5% | -$11.2K | ﹤0.01% | 5848 |
|
|
2023
Q4 | $128K | Buy |
28,039
+13,986
| +100% | +$47.2K | ﹤0.01% | 6043 |
|
|
2023
Q3 | $55.5K | Sell |
14,053
-14,632
| -51% | -$55.3K | ﹤0.01% | 6234 |
|
|
2023
Q2 | $89.8K | Buy |
28,685
+22,743
| +383% | +$92.8K | ﹤0.01% | 6100 |
|
|
2023
Q1 | $26.9K | Buy |
5,942
+5,870
| +8,153% | +$30.7K | ﹤0.01% | 6871 |
|
|
2022
Q4 | $297 | Sell |
72
-3,273
| -98% | -$11.2K | ﹤0.01% | 10262 |
|
|
2022
Q3 | $11K | Buy |
3,345
+2,744
| +457% | +$6.87K | ﹤0.01% | 8306 |
|
|
2022
Q2 | $1K | Sell |
601
-1,132
| -65% | -$3.34K | ﹤0.01% | 9900 |
|
|
2022
Q1 | $7K | Buy |
1,733
+612
| +55% | +$4K | ﹤0.01% | 8825 |
|
|
2021
Q4 | $12K | Buy |
1,121
+1,113
| +13,913% | +$12.4K | ﹤0.01% | 8562 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 9833 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 9620 |
|
|
2021
Q1 | $0 | Sell |
8
-291
| -97% | -$5.29K | ﹤0.01% | 9274 |
|
|
2020
Q4 | $6K | Buy |
+299
| New | +$5.99K | ﹤0.01% | 7762 |
|
|
2020
Q1 | – | Sell |
-87
| Closed | -$1K | – | 8204 |
|
|
2019
Q4 | $1K | Sell |
87
-1,255
| -94% | -$12K | ﹤0.01% | 7957 |
|
|
2019
Q3 | $12K | Buy |
+1,342
| New | +$14.7K | ﹤0.01% | 7051 |
|
|
2019
Q2 | – | Sell |
-213
| Closed | -$7K | – | 8029 |
|
|
2019
Q1 | $7K | Sell |
213
-169
| -44% | -$8.66K | ﹤0.01% | 7011 |
|
|
2018
Q4 | $23K | Sell |
382
-227
| -37% | -$22.4K | ﹤0.01% | 6667 |
|
|
2018
Q3 | $85K | Buy |
609
+387
| +174% | +$47K | ﹤0.01% | 5724 |
|
|
2018
Q2 | $27K | Buy |
222
+1
| +0.5% | +$85 | ﹤0.01% | 6475 |
|
|
2018
Q1 | $20K | Buy |
221
+80
| +57% | +$6.78K | ﹤0.01% | 6412 |
|
|
2017
Q4 | $8K | Buy |
141
+140
| +14,000% | +$6.31K | ﹤0.01% | 7159 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7881 |
|
|
2017
Q2 | $0 | Sell |
1
-313
| -100% | -$16K | ﹤0.01% | 7845 |
|
|
2017
Q1 | $17K | Sell |
314
-106
| -25% | -$5.26K | ﹤0.01% | 6261 |
|
|
2016
Q4 | $16K | Sell |
420
-23
| -5% | -$933 | ﹤0.01% | 6646 |
|
|
2016
Q3 | $18K | Buy |
443
+442
| +44,200% | +$20.1K | ﹤0.01% | 6381 |
|
|
2016
Q2 | $0 | Sell |
1
-127
| -99% | -$10K | ﹤0.01% | 7863 |
|
|
2016
Q1 | $10K | Sell |
128
-12,825
| -99% | -$1.01M | ﹤0.01% | 6668 |
|
|
2015
Q4 | $978K | Buy |
12,953
+12,021
| +1,290% | +$1.93M | ﹤0.01% | 3423 |
|
|
2015
Q3 | $357K | Buy |
932
+839
| +902% | +$378K | ﹤0.01% | 4175 |
|
|
2015
Q2 | $39K | Buy |
93
+76
| +447% | +$31.8K | ﹤0.01% | 6224 |
|
|
2015
Q1 | $8K | Buy |
+17
| New | +$8.07K | ﹤0.01% | 7816 |
|
Other funds holding LRMR
DM
BOCH
ACM
DCM
VCM
DCM
DTC